Billion-dollar biotech company's focus expands to include COVID
Published Date: 9/22/2021
Source: phys.org
Harlan and Chad Robins started Seattle-based Adaptive Biotechnologies 12 years ago to find a cure for cancer. Now, they have broadened their mission to take on COVID-19.
